Clinical Research

BGB-3111 (COVID)

The primary objective of this study is to evaluate if the addition of zanubrutinib to supportive care increases the respiratory failure-free survival rate at Day 28 in participants hospitalized for Corona Virus Disease 2019 (COVID-19) and pulmonary distress.

For more information on this clinical trail Click Here

The office of Dr. Joseph Gathe, Jr. is pleased to offer both in office visits as well as telemedicine services.

(Mask donated to the staff by designer David Peck. Thank you)

Please call for more details
713 526 9821

Download Zoom which will be our telemedicine partner.

4900 Fannin st.
Houston Tx. 77004
713 526 9821

Copyright © 2020 - All rights reserved - Website Hosting and Maintenance provided By JRS